Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 28;20(1):2.
doi: 10.1186/s12885-019-6472-9.

Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers

Helen Fowler  1 , Aurelien Belot  2 , Libby Ellis  2 , Camille Maringe  2 , Miguel Angel Luque-Fernandez  3   4 , Edmund Njeru Njagi  2 , Neal Navani  5   6 , Diana Sarfati  7 , Bernard Rachet  2
Affiliations

Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers

Helen Fowler et al. BMC Cancer. .

Abstract

Background: The presence of comorbidity affects the care of cancer patients, many of whom are living with multiple comorbidities. The prevalence of cancer comorbidity, beyond summary metrics, is not well known. This study aims to estimate the prevalence of comorbid conditions among cancer patients in England, and describe the association between cancer comorbidity and socio-economic position, using population-based electronic health records.

Methods: We linked England cancer registry records of patients diagnosed with cancer of the colon, rectum, lung or Hodgkin lymphoma between 2009 and 2013, with hospital admissions records. A comorbidity was any one of fourteen specific conditions, diagnosed during hospital admission up to 6 years prior to cancer diagnosis. We calculated the crude and age-sex adjusted prevalence of each condition, the frequency of multiple comorbidity combinations, and used logistic regression and multinomial logistic regression to estimate the adjusted odds of having each condition and the probability of having each condition as a single or one of multiple comorbidities, respectively, by cancer type.

Results: Comorbidity was most prevalent in patients with lung cancer and least prevalent in Hodgkin lymphoma patients. Up to two-thirds of patients within each of the four cancer patient cohorts we studied had at least one comorbidity, and around half of the comorbid patients had multiple comorbidities. Our study highlighted common comorbid conditions among the cancer patient cohorts. In all four cohorts, the odds of having a comorbidity and the probability of multiple comorbidity were consistently highest in the most deprived cancer patients.

Conclusions: Cancer healthcare guidelines may need to consider prominent comorbid conditions, particularly to benefit the prognosis of the most deprived patients who carry the greater burden of comorbidity. Insight into patterns of cancer comorbidity may inform further research into the influence of specific comorbidities on socio-economic inequalities in receipt of cancer treatment and in short-term mortality.

Keywords: Cancer; Comorbidity; Deprivation; England; Epidemiology; Multimorbidity; Prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Crude and adjusted prevalence (%) of fourteen comorbidities among cancer patients in England, by cancer
Fig. 2
Fig. 2
Relative frequency (%) of five common conditions as a single comorbidity or with another comorbidity, by cancer
Fig. 3
Fig. 3
Probability (%) of condition present as single or multiple comorbidity, by deprivation group (colon cancer)
See this image and copyright information in PMC

References

    1. Porta MS, Greenland S, Last JM. A dictionary of epidemiology: Oxford University press; 2014. Available from: http://www.oxfordreference.com/view/10.1093/acref/9780195314496.001.0001.... Accessed 31 Oct 2018. - DOI
    1. Gumey J, Sarfati D, Stanley J. The impact of patient comorbidity on cancer stage at diagnosis. BJC. 2015;113:1375–1380. doi: 10.1038/bjc.2015.355. - DOI - PMC - PubMed
    1. Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–350. doi: 10.3322/caac.21342. - DOI - PubMed
    1. Salika T, Lyratzopoulos G, Whitaker KL, Waller J, Renzi C. Do comorbidities influence help-seeking for cancer alarm symptoms? A population-based survey in England. J Public Health. 2018;40(2):340–349. doi: 10.1093/pubmed/fdx072. - DOI - PMC - PubMed
    1. Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition--multimorbidity. JAMA. 2012;307(23):2493–2494. doi: 10.1001/jama.2012.5265. - DOI - PMC - PubMed